{"name":"NeuPharma, Inc.","slug":"neupharma-inc","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMimgFBVV95cUxNZGc0OTI3ZnBVUDlQNmtkWWNoQ21NNlNXZkQ5MndvTzVuSlVKOUhDdERtcDFEWGtXSkpuSHJZMGlsR0tZRVRNd00zbm9mZ1lNeDRndHY1QWtmd3hZUFBnNUc3Y3FBS2xQVzVZMFN5a1NNUy1kemRuNXZIdTZSdm9QYk5feVZ5eWR4Z2UwUDlHSVpmYlplYXR5eGx3?oc=5","date":"2026-03-12","type":"pipeline","source":"Pharmaceutical Technology","summary":"Curatis and Neupharma sign development agreement for corticorelin in Japan - Pharmaceutical Technology","headline":"Curatis and Neupharma sign development agreement for corticorelin in Japan","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMilwFBVV95cUxQNnRxWjdzeWFnQkpzd1ZJdUoweGNjd3pobXVIcGx4d2hseHYzQnRmSVc4QUF6MDhsUXd3TXM5dktNZlg0T2JXS2tDOV9kMnB1TWlITDNNR3U5SHlENHcwLXpRb3Y4UEpXSGdaQjFqS2p5aEFjV1p4NmVLZkZCX29FM1lZU1hsMDd6ZzBqZDZUa2szMEs4UGdV?oc=5","date":"2026-03-10","type":"regulatory","source":"Yahoo Finance","summary":"Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Treatment of Peritumoral Brain Edema in Japan - Yahoo Finance","headline":"Curatis and Neupharma Announce Exclusive Licensing Agreement to Develop and Market Corticorelin (C-PTBE-01) for the Trea","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiywFBVV95cUxNdjdDLVR2b2NUYkNySkJZbS1RMm44U3FnQ0Exc3RTLUUyZEhCdmRrbWRNM3N5VVd0QUNpVFQwV2lZX0FYTXo4SEs3X0JURzl0WHNHcDFOdFB1anlJRmI4N3c3b3lEV3VtSVB3SmFBUUZCZGEwbDNad0l4UFRwZEMyS3k3YnBjRS1FdlJTYjdLRTVkZVMyNmJLeUZfUjd2S1ltanZjaWczajE5aC16OVNqSy1vX0RHZnJqZklfSHFjSjVCTWhsQWhNd09Qbw?oc=5","date":"2026-03-10","type":"regulatory","source":"TipRanks","summary":"Curatis Licenses Brain Edema Drug Corticorelin to Neupharma for Japanese Market - TipRanks","headline":"Curatis Licenses Brain Edema Drug Corticorelin to Neupharma for Japanese Market","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}